Common Variants at 30 Loci Contribute to Polygenic Dyslipidemia

Blood low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol and triglyceride levels are risk factors for cardiovascular disease. To dissect the polygenic basis of these traits, we conducted genome-wide association screens in 19,840 individuals and replication in up to 20,623 individuals. We identified 30 distinct loci associated with lipoprotein concentrations (each with P < 5 x 10(-8)), including 11 loci that reached genome-wide significance for the first time. The 11 newly defined loci include common variants associated with LDL cholesterol near ABCG8, MAFB, HNF1A and TIMD4; with HDL cholesterol near ANGPTL4, FADS1-FADS2-FADS3, HNF4A, LCAT, PLTP and TTC39B; and with triglycerides near AMAC1L2, FADS1-FADS2-FADS3 and PLTP. The proportion of individuals exceeding clinical cut points for high LDL cholesterol, low HDL cholesterol and high triglycerides varied according to an allelic dosage score (P < 10(-15) for each trend). These results suggest that the cumulative effect of multiple common variants contributes to polygenic dyslipidemia.

Citing Articles

A Comprehensive Review of the Genetics of Dyslipidemias and Risk of Atherosclerotic Cardiovascular Disease.

Kalwick M, Roth M Nutrients. 2025; 17(4).

PMID: 40004987 PMC: 11858766. DOI: 10.3390/nu17040659.

Empowering genome-wide association studies via a visualizable test based on the regional association score.

Jiang Y, Zhang H Proc Natl Acad Sci U S A. 2025; 122(9):e2419721122.

PMID: 39999171 PMC: 11892588. DOI: 10.1073/pnas.2419721122.

XbaI polymorphism in the APOB gene and its association with increased cholesterol in children and adolescents: Ouro Preto study.

de Souza T, Batista A, de Menezes-Junior L, Costa A, Louzada C, Lourencao L Sci Rep. 2024; 14(1):31452.

PMID: 39733208 PMC: 11682059. DOI: 10.1038/s41598-024-83099-8.

Associations of Blood Lipid-Related Polygenic Scores, Lifestyle Factors and Their Combined Effects with Risk of Coronary Artery Disease in the UK Biobank Cohort.

Choi J, Wen W, Jia G, Tao R, Long J, Shu X J Cardiovasc Transl Res. 2024; .

PMID: 39680354 DOI: 10.1007/s12265-024-10578-8.

Long Noncoding RNA TRIBAL Links the 8q24.13 Locus to Hepatic Lipid Metabolism and Coronary Artery Disease.

Soubeyrand S, Lau P, Nikpay M, Ma L, Bjorkegren J, McPherson R Circ Genom Precis Med. 2024; 17(6):e004674.

PMID: 39624902 PMC: 11651355. DOI: 10.1161/CIRCGEN.124.004674.

References

Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P . Cardiovascular risk factor changes in Finland, 1972-1997. Int J Epidemiol. 2000; 29(1):49-56. DOI: 10.1093/ije/29.1.49. View

Cohen J, Pertsemlidis A, Kotowski I, Graham R, Garcia C, Hobbs H . Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat Genet. 2005; 37(2):161-5. DOI: 10.1038/ng1509. View

Kajinami K, Brousseau M, Nartsupha C, Ordovas J, Schaefer E . ATP binding cassette transporter G5 and G8 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin. J Lipid Res. 2004; 45(4):653-6. DOI: 10.1194/jlr.M300278-JLR200. View

TOOMEY R, WAKIL S . Studies on the mechanism of fatty acid synthesis. XVI. Preparation and general properties of acyl-malonyl acyl carrier protein-condensing enzyme from Escherichia coli. J Biol Chem. 1966; 241(5):1159-65. View

Romeo S, Pennacchio L, Fu Y, Boerwinkle E, Tybjaerg-Hansen A, Hobbs H . Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet. 2007; 39(4):513-6. PMC: 2762948. DOI: 10.1038/ng1984. View

Benjannet S, Rhainds D, Essalmani R, Mayne J, Wickham L, Jin W . NARC-1/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol. J Biol Chem. 2004; 279(47):48865-75. DOI: 10.1074/jbc.M409699200. View

Schaeffer L, Gohlke H, Muller M, Heid I, Palmer L, Kompauer I . Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum Mol Genet. 2006; 15(11):1745-56. DOI: 10.1093/hmg/ddl117. View

Berglund G, Elmstahl S, Janzon L, Larsson S . The Malmo Diet and Cancer Study. Design and feasibility. J Intern Med. 1993; 233(1):45-51. DOI: 10.1111/j.1365-2796.1993.tb00647.x. View

Odom D, Zizlsperger N, Gordon D, Bell G, Rinaldi N, Murray H . Control of pancreas and liver gene expression by HNF transcription factors. Science. 2004; 303(5662):1378-81. PMC: 3012624. DOI: 10.1126/science.1089769. View

10.

Saxena R, Voight B, Lyssenko V, Burtt N, de Bakker P, Chen H . Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007; 316(5829):1331-6. DOI: 10.1126/science.1142358. View

11.

. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct.... Lancet. 1992; 339(8796):753-70. View

12.

Ek J, Rose C, Jensen D, Glumer C, Borch-Johnsen K, Jorgensen T . The functional Thr130Ile and Val255Met polymorphisms of the hepatocyte nuclear factor-4alpha (HNF4A): gene associations with type 2 diabetes or altered beta-cell function among Danes. J Clin Endocrinol Metab. 2005; 90(5):3054-9. DOI: 10.1210/jc.2004-2159. View

13.

Miyanishi M, Tada K, Koike M, Uchiyama Y, Kitamura T, Nagata S . Identification of Tim4 as a phosphatidylserine receptor. Nature. 2007; 450(7168):435-9. DOI: 10.1038/nature06307. View

14.

Maxwell K, Fisher E, Breslow J . Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment. Proc Natl Acad Sci U S A. 2005; 102(6):2069-74. PMC: 546019. DOI: 10.1073/pnas.0409736102. View

15.

Hayhurst G, Lee Y, Lambert G, Ward J, Gonzalez F . Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol. 2001; 21(4):1393-403. PMC: 99591. DOI: 10.1128/MCB.21.4.1393-1403.2001. View

16.

Kathiresan S, Melander O, Guiducci C, Surti A, Burtt N, Rieder M . Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 2008; 40(2):189-97. PMC: 2682493. DOI: 10.1038/ng.75. View

17.

Kathiresan S, Melander O, Anevski D, Guiducci C, Burtt N, Roos C . Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med. 2008; 358(12):1240-9. DOI: 10.1056/NEJMoa0706728. View

18.

Schadt E, Molony C, Chudin E, Hao K, Yang X, Lum P . Mapping the genetic architecture of gene expression in human liver. PLoS Biol. 2008; 6(5):e107. PMC: 2365981. DOI: 10.1371/journal.pbio.0060107. View

19.

Willer C, Sanna S, Jackson A, Scuteri A, Bonnycastle L, Clarke R . Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 2008; 40(2):161-9. PMC: 5206900. DOI: 10.1038/ng.76. View

20.

Petersen H, Hilpert J, Jacobsen C, Lauwers A, Roebroek A, Willnow T . Low-density lipoprotein receptor-related protein interacts with MafB, a regulator of hindbrain development. FEBS Lett. 2004; 565(1-3):23-7. DOI: 10.1016/j.febslet.2004.03.069. View